Q-switched laser patents typically claim nanosecond-range pulse durations and rely on thermal or photomechanical tissue effects, while picosecond laser patents claim shorter pulse durations that favour photoacoustic disruption with less collateral thermal damage. In practice, many filings in this dataset claim both regimes within a single family, distinguishing them by pulse-duration ranges and fluence thresholds rather than by device architecture. When scoping a filing, check whether the claimed pulse-duration range overlaps prior art in both categories, since examiners often treat them as adjacent rather than distinct technical fields.

The ranked assignee list shows a clear volume leader with 305 records, well ahead of the fifth-ranked holder at 130, but the top 5 combined still account for only 19.3% of all 4,961 records in scope. This means leadership by volume does not translate into control of the field the way it might in a more concentrated technology area. Several of the largest historical filers show no filings in the most recent year, though this may reflect publication lag rather than an actual exit from the space.

B23K covers welding, soldering and brazing, and it carries the largest single share of records in this dataset at 25.2% of the 4,961 records in scope — larger than the surgical (A61B) or laser-source (H01S) classes. This happens because picosecond and Q-switched pulse-parameter claims (duration, fluence, dosage) are often written generically enough to cover both metal surface processing and tissue interaction, and the same underlying physics of rapid energy deposition applies to both. Anyone drafting or searching claims in this space should check materials-processing art, not just medical-device art.

Filings peaked at 362 in 2019 and had fallen to 105 by 2024, a decline of 61% from 2021's 270 — a real drop across a comparable, complete window. However, 2025 and 2026 figures in any such dataset are understated because publication typically lags filing by around 18 months, so it is premature to call the most recent years a continuation of that decline. The safest reading is that the initial filing surge has passed and the field has moved into a lower, more selective filing rate.

The IPC composition suggests thinner claim density in areas like session-interval optimisation, multi-wavelength ink-clearance sequencing and photoacoustic feedback dosimetry, compared with the dense core art in pulse-duration and fluence claims. These are process- and protocol-level claims rather than pure device claims, which tend to attract less crowded prior art. A first claim in these areas would likely combine a specific parameter range (session interval, wavelength sequence, or feedback signal) with a defined clinical or material outcome, rather than claiming the laser source itself.